Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema: A Subanalysis of the RESTORE (Extension) Study.

Karst SG, Deak GG, Gerendas BS, Waldstein SM, Lammer J, Simader C, Guerin T, Schmidt-Erfurth UM.

JAMA Ophthalmol. 2018 Apr 1;136(4):315-321. doi: 10.1001/jamaophthalmol.2017.6135.

2.

The Distribution of Leakage on Fluorescein Angiography in Diabetic Macular Edema: A New Approach to Its Etiology.

Haj Najeeb B, Simader C, Deak G, Vass C, Gamper J, Montuoro A, Gerendas BS, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):3986-3990. doi: 10.1167/iovs.17-21510.

PMID:
28796876
3.

Predictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedema.

Gerendas BS, Prager S, Deak G, Simader C, Lammer J, Waldstein SM, Guerin T, Kundi M, Schmidt-Erfurth UM.

Br J Ophthalmol. 2018 Feb;102(2):195-203. doi: 10.1136/bjophthalmol-2017-310483. Epub 2017 Jul 19.

PMID:
28724636
4.

Impact of B-Scan Averaging on Spectralis Optical Coherence Tomography Image Quality before and after Cataract Surgery.

Podkowinski D, Sharian Varnousfaderani E, Simader C, Bogunovic H, Philip AM, Gerendas BS, Schmidt-Erfurth U, Waldstein SM.

J Ophthalmol. 2017;2017:8148047. doi: 10.1155/2017/8148047. Epub 2017 May 23.

5.

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.

Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG.

Ophthalmology. 2016 Nov;123(11):2376-2385. doi: 10.1016/j.ophtha.2016.07.032. Epub 2016 Sep 17.

PMID:
27651226
6.

Multivendor Spectral-Domain Optical Coherence Tomography Dataset, Observer Annotation Performance Evaluation, and Standardized Evaluation Framework for Intraretinal Cystoid Fluid Segmentation.

Wu J, Philip AM, Podkowinski D, Gerendas BS, Langs G, Simader C, Waldstein SM, Schmidt-Erfurth UM.

J Ophthalmol. 2016;2016:3898750. doi: 10.1155/2016/3898750. Epub 2016 Aug 4.

7.

A novel benchmark model for intelligent annotation of spectral-domain optical coherence tomography scans using the example of cyst annotation.

Shahrian Varnousfaderani E, Wu J, Vogl WD, Philip AM, Montuoro A, Leitner R, Simader C, Waldstein SM, Gerendas BS, Schmidt-Erfurth U.

Comput Methods Programs Biomed. 2016 Jul;130:93-105. doi: 10.1016/j.cmpb.2016.03.012. Epub 2016 Mar 16.

PMID:
27208525
8.

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.

Waldstein SM, Simader C, Staurenghi G, Chong NV, Mitchell P, Jaffe GJ, Lu C, Katz TA, Schmidt-Erfurth U.

Ophthalmology. 2016 Jul;123(7):1521-9. doi: 10.1016/j.ophtha.2016.03.037. Epub 2016 May 4.

PMID:
27157149
9.

Choroidal thickness maps from spectral domain and swept source optical coherence tomography: algorithmic versus ground truth annotation.

Philip AM, Gerendas BS, Zhang L, Faatz H, Podkowinski D, Bogunovic H, Abramoff MD, Hagmann M, Leitner R, Simader C, Sonka M, Waldstein SM, Schmidt-Erfurth U.

Br J Ophthalmol. 2016 Oct;100(10):1372-6. doi: 10.1136/bjophthalmol-2015-307985. Epub 2016 Jan 14.

10.

Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.

Waldstein SM, Philip AM, Leitner R, Simader C, Langs G, Gerendas BS, Schmidt-Erfurth U.

JAMA Ophthalmol. 2016 Feb;134(2):182-90. doi: 10.1001/jamaophthalmol.2015.4948.

PMID:
26661463
11.

Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography.

Munk MR, Jampol LM, Simader C, Huf W, Mittermüller TJ, Jaffe GJ, Schmidt-Erfurth U.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6724-33. doi: 10.1167/iovs.15-17042.

PMID:
26567783
12.

Choroidal Line Scan Measurements in Swept-Source Optical Coherence Tomography as Surrogates for Volumetric Thickness Assessment.

Gerendas BS, Hecht A, Kundi M, Waldstein SM, Deak G, Simader C, Montuoro A, Schmidt-Erfurth U, Funk M.

Am J Ophthalmol. 2016 Feb;162:150-158.e1. doi: 10.1016/j.ajo.2015.10.020. Epub 2015 Nov 3.

PMID:
26546563
13.

Predictive Value of Retinal Morphology for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular AMD.

Waldstein SM, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U.

Ophthalmology. 2016 Jan;123(1):60-9. doi: 10.1016/j.ophtha.2015.09.013. Epub 2015 Oct 17.

PMID:
26481821
14.

Spatio-Temporal Signatures to Predict Retinal Disease Recurrence.

Vogl WD, Waldstein SM, Gerendas BS, Simader C, Glodan AM, Podkowinski D, Schmidt-Erfurth U, Langs G.

Inf Process Med Imaging. 2015;24:152-63.

PMID:
26221672
15.

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.

Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF.

Ophthalmology. 2015 Oct;122(10):2044-52. doi: 10.1016/j.ophtha.2015.06.017. Epub 2015 Jul 18.

PMID:
26198808
16.

Reply: To PMID 25068637.

Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group.

Am J Ophthalmol. 2015 Mar;159(3):608. doi: 10.1016/j.ajo.2014.12.016. No abstract available.

PMID:
25681024
17.

Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography.

Waldstein SM, Faatz H, Szimacsek M, Glodan AM, Podkowinski D, Montuoro A, Simader C, Gerendas BS, Schmidt-Erfurth U.

Eye (Lond). 2015 Mar;29(3):409-15. doi: 10.1038/eye.2014.319. Epub 2015 Jan 16.

18.

Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.

Schmidt-Erfurth U, Waldstein SM, Deak GG, Kundi M, Simader C.

Ophthalmology. 2015 Apr;122(4):822-32. doi: 10.1016/j.ophtha.2014.11.017. Epub 2015 Jan 9.

PMID:
25578255
19.

Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments.

Waldstein SM, Gerendas BS, Montuoro A, Simader C, Schmidt-Erfurth U.

Br J Ophthalmol. 2015 Jun;99(6):794-800. doi: 10.1136/bjophthalmol-2014-305573. Epub 2015 Jan 6.

PMID:
25563763
20.

Motion artefact correction in retinal optical coherence tomography using local symmetry.

Montuoro A, Wu J, Waldstein S, Gerendas B, Langs G, Simader C, Schmidt-Erfurth U.

Med Image Comput Comput Assist Interv. 2014;17(Pt 2):130-7.

PMID:
25485371
21.

Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema.

Gerendas BS, Waldstein SM, Simader C, Deak G, Hajnajeeb B, Zhang L, Bogunovic H, Abramoff MD, Kundi M, Sonka M, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Nov;158(5):1039-48. doi: 10.1016/j.ajo.2014.08.001. Epub 2014 Aug 12.

22.

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study.

Ogura Y, Terasaki H, Gomi F, Yuzawa M, Iida T, Honda M, Nishijo K, Sowade O, Komori T, Schmidt-Erfurth U, Simader C, Chong V; VIEW 2 Investigators.

Br J Ophthalmol. 2015 Jan;99(1):92-7. doi: 10.1136/bjophthalmol-2014-305076. Epub 2014 Aug 8.

23.

Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy.

Ritter M, Simader C, Bolz M, Deák GG, Mayr-Sponer U, Sayegh R, Kundi M, Schmidt-Erfurth UM.

Br J Ophthalmol. 2014 Dec;98(12):1629-35. doi: 10.1136/bjophthalmol-2014-305186. Epub 2014 Jul 30.

PMID:
25079064
24.

Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study.

Ogura Y, Roider J, Korobelnik JF, Holz FG, Simader C, Schmidt-Erfurth U, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group.

Am J Ophthalmol. 2014 Nov;158(5):1032-8. doi: 10.1016/j.ajo.2014.07.027. Epub 2014 Jul 25.

PMID:
25068637
25.

Intravitreal aflibercept for diabetic macular edema.

Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM.

Ophthalmology. 2014 Nov;121(11):2247-54. doi: 10.1016/j.ophtha.2014.05.006. Epub 2014 Jul 8.

PMID:
25012934
26.

Differential diagnosis of macular edema of different pathophysiologic origins by spectral domain optical coherence tomography.

Munk MR, Sacu S, Huf W, Sulzbacher F, Mittermüller TJ, Eibenberger K, Rezar S, Bolz M, Kiss CG, Simader C, Schmidt-Erfurth U.

Retina. 2014 Nov;34(11):2218-32. doi: 10.1097/IAE.0000000000000228.

PMID:
25011028
27.

A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy.

Simader C, Sayegh RG, Montuoro A, Azhary M, Koth AL, Baratsits M, Sacu S, Prünte C, Kreil DP, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Sep;158(3):557-66.e1. doi: 10.1016/j.ajo.2014.05.026. Epub 2014 May 28.

PMID:
24879944
28.

Impact of vitreomacular adhesion on ranibizumab mono- and combination therapy for neovascular age-related macular degeneration.

Waldstein SM, Ritter M, Simader C, Mayr-Sponer U, Kundi M, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Aug;158(2):328-336.e1. doi: 10.1016/j.ajo.2014.04.028. Epub 2014 May 2.

PMID:
24794282
29.

A systematic correlation of morphology and function using spectral domain optical coherence tomography and microperimetry in patients with geographic atrophy.

Sayegh RG, Kiss CG, Simader C, Kroisamer J, Montuoro A, Mittermüller TJ, Azhary M, Bolz M, Kreil DP, Schmidt-Erfurth U.

Br J Ophthalmol. 2014 Aug;98(8):1050-5. doi: 10.1136/bjophthalmol-2014-305195. Epub 2014 Apr 7.

PMID:
24711655
30.

Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.

Simader C, Ritter M, Bolz M, Deák GG, Mayr-Sponer U, Golbaz I, Kundi M, Schmidt-Erfurth UM.

Ophthalmology. 2014 Jun;121(6):1237-45. doi: 10.1016/j.ophtha.2013.12.029. Epub 2014 Mar 28.

PMID:
24684838
31.

Influence of orthostasis and daytime on retinal thickness in uveitis-associated cystoid macular edema.

Munk MR, Kiss CG, Ekmekcioglu C, Huf W, Sulzbacher F, Gerendas B, Simader C, Schmidt-Erfurth U.

Curr Eye Res. 2014 Apr;39(4):395-402. doi: 10.3109/02713683.2013.845227. Epub 2013 Nov 11.

PMID:
24215573
32.

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.

Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, Ho AC, Ogura Y, Simader C, Jaffe GJ, Slakter JS, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Sowade O, Zeitz O, Norenberg C, Sandbrink R, Heier JS.

Ophthalmology. 2014 Jan;121(1):193-201. doi: 10.1016/j.ophtha.2013.08.011. Epub 2013 Sep 29.

PMID:
24084500
33.

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.

Korobelnik JF, Holz FG, Roider J, Ogura Y, Simader C, Schmidt-Erfurth U, Lorenz K, Honda M, Vitti R, Berliner AJ, Hiemeyer F, Stemper B, Zeitz O, Sandbrink R; GALILEO Study Group.

Ophthalmology. 2014 Jan;121(1):202-208. doi: 10.1016/j.ophtha.2013.08.012. Epub 2013 Sep 29.

34.

Systematic correlation of morphologic alterations and retinal function in eyes with uveitis-associated cystoid macular oedema during development, resolution and relapse.

Munk MR, Kiss CG, Steiner I, Sulzbacher F, Roberts P, Kroh M, Montuoro A, Simader C, Schmidt-Erfurth U.

Br J Ophthalmol. 2013 Oct;97(10):1289-96. doi: 10.1136/bjophthalmol-2012-303052. Epub 2013 Aug 2.

PMID:
23913247
35.

One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment.

Munk MR, Kiss C, Huf W, Sulzbacher F, Roberts P, Mittermüller TJ, Sacu S, Simader C, Schmidt-Erfurth U.

Am J Ophthalmol. 2013 Oct;156(4):633-43. doi: 10.1016/j.ajo.2013.05.037. Epub 2013 Jul 24.

PMID:
23891335
36.

Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration.

Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, Papp A, Simader C, Schmidt-Erfurth U.

Ophthalmology. 2013 Dec;120(12):2620-2629. doi: 10.1016/j.ophtha.2013.05.032. Epub 2013 Jul 16.

PMID:
23870300
37.

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study.

Lang GE, Berta A, Eldem BM, Simader C, Sharp D, Holz FG, Sutter F, Gerstner O, Mitchell P; RESTORE Extension Study Group.

Ophthalmology. 2013 Oct;120(10):2004-12. doi: 10.1016/j.ophtha.2013.02.019. Epub 2013 May 29.

PMID:
23725735
38.

Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema.

Munk MR, Bolz M, Huf W, Sulzbacher F, Roberts P, Simader C, Rückert R, Kiss CG.

Retina. 2013 Sep;33(8):1673-83. doi: 10.1097/IAE.0b013e318285cc52.

PMID:
23584695
39.

Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.

Munk M, Kiss C, Huf W, Sulzbacher F, Bolz M, Sayegh R, Eisenkölbl S, Simader C, Schmidt-Erfurth U.

Retina. 2013 Oct;33(9):1915-22. doi: 10.1097/IAE.0b013e318285cc0c.

PMID:
23584693
40.

VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study.

Holz FG, Roider J, Ogura Y, Korobelnik JF, Simader C, Groetzbach G, Vitti R, Berliner AJ, Hiemeyer F, Beckmann K, Zeitz O, Sandbrink R.

Br J Ophthalmol. 2013 Mar;97(3):278-84. doi: 10.1136/bjophthalmol-2012-301504. Epub 2013 Jan 7. Erratum in: Br J Ophthalmol. 2015 Dec;99(12):1746.

PMID:
23298885
41.

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Soo Y, Anderesi M, Groetzbach G, Sommerauer B, Sandbrink R, Simader C, Schmidt-Erfurth U; VIEW 1 and VIEW 2 Study Groups.

Ophthalmology. 2012 Dec;119(12):2537-48. doi: 10.1016/j.ophtha.2012.09.006. Epub 2012 Oct 17. Erratum in: Ophthalmology. 2013 Jan;120(1):209-10.

PMID:
23084240
42.

Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.

Larsen M, Schmidt-Erfurth U, Lanzetta P, Wolf S, Simader C, Tokaji E, Pilz S, Weisberger A; MONT BLANC Study Group.

Ophthalmology. 2012 May;119(5):992-1000. doi: 10.1016/j.ophtha.2012.02.002. Epub 2012 Mar 17.

PMID:
22424834
43.

Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study.

Waldstein SM, Sponer U, Simader C, Sacu S, Schmidt-Erfurth U.

Retina. 2012 Mar;32(3):424-33. doi: 10.1097/IAE.0b013e3182278b80.

PMID:
22105497
44.

Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration.

Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhöfer G, Schmidt-Erfurth U, Schmetterer L.

Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8174-8. doi: 10.1167/iovs.11-7522.

PMID:
21873668
45.

A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.

Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U.

Ophthalmology. 2011 Sep;118(9):1844-51. doi: 10.1016/j.ophtha.2011.01.043. Epub 2011 Apr 15.

PMID:
21496928
46.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A; RESTORE study group.

Ophthalmology. 2011 Apr;118(4):615-25. doi: 10.1016/j.ophtha.2011.01.031.

47.

Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.

Schmidt-Erfurth U, Eldem B, Guymer R, Korobelnik JF, Schlingemann RO, Axer-Siegel R, Wiedemann P, Simader C, Gekkieva M, Weichselberger A; EXCITE Study Group.

Ophthalmology. 2011 May;118(5):831-9. doi: 10.1016/j.ophtha.2010.09.004. Epub 2010 Dec 13.

PMID:
21146229
48.

Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy.

Golbaz I, Ahlers C, Stock G, Schütze C, Schriefl S, Schlanitz F, Simader C, Prünte C, Schmidt-Erfurth UM.

Invest Ophthalmol Vis Sci. 2011 Mar 1;52(3):1599-605. doi: 10.1167/iovs.09-5018.

PMID:
21051733
49.

Evaluation of optical coherence tomography findings in age-related macular degeneration: a reproducibility study of two independent reading centres.

Ritter M, Elledge J, Simader C, Deak GG, Benesch T, Blodi BA, Schmidt-Erfurth UM.

Br J Ophthalmol. 2011 Mar;95(3):381-5. doi: 10.1136/bjo.2009.175976. Epub 2010 Aug 30.

50.

High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up.

Sayegh RG, Georgopoulos M, Geitzenauer W, Simader C, Kiss C, Schmidt-Erfurth U.

Ophthalmology. 2010 Oct;117(10):2010-7, 2017.e1-2. doi: 10.1016/j.ophtha.2010.01.041. Epub 2010 Jun 8.

PMID:
20570362

Supplemental Content

Loading ...
Support Center